类固醇在门诊COVID-19的治疗:一个多中心随机对照试验
Babak Amra1, Atefeh Vaezi2, Forogh Soltaninejad3
1Department of Pulmonology, Bamdad Respiratory Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Advanced biomedical research
|July 12, 2023
概括
在非严重的COVID-19门诊患者中,皮质类固醇并没有显著减少住院治疗. 这项研究建议在门诊COVID-19治疗中避免使用皮质类固醇,因为它对预防严重后果没有任何作用.
科学领域:
- 传染性疾病 传染性疾病
- 临床药理学 临床药理学
- 公共卫生 公共卫生
背景情况:
- 早期治疗COVID-19对于减少严重后果至关重要.
- 皮质类固醇在门诊COVID-19管理中的作用尚不清楚.
- 这项研究解决了在非严重病例中了解皮质类固醇疗效的需要.
研究的目的:
- 为了评估皮质类固醇在预防非严重COVID-19患者的住院治疗中的有效性.
- 为了确定早期的皮质类固醇干预是否会影响门诊COVID-19病例的疾病进展.
主要方法:
- 进行了一项多中心随机对照试验.
- 75名不严重的COVID-19患者在症状发作7至14天之间被招募.
- 参与者接受了普雷迪尼索隆或安慰剂,住院是主要结果.
主要成果:
- 与安慰剂组 (7.9%) 相比,在普雷迪尼索隆组 (10.8%) 的住院率略高.
- 这种住院率的差异在统计学上并不显著 (P值>0.05).
- 每组中都有一名患者报告了不良事件,导致药物停用.
结论:
- 皮质类固醇在预防不严重的COVID-19门诊患者住院方面表现为无效.
- 目前的证据不支持在门诊COVID-19治疗中使用皮质类固醇.
- 可能需要进一步的研究来探索替代的门诊疗法.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
249
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
249
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
308
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
308
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
155
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
155
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
198
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
198
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


